138 related articles for article (PubMed ID: 33746136)
21. Follicular thyroid carcinoma: differences in clinical relevance between minimally invasive and widely invasive tumors.
Podda M; Saba A; Porru F; Reccia I; Pisanu A
World J Surg Oncol; 2015 Jun; 13():193. PubMed ID: 26041024
[TBL] [Abstract][Full Text] [Related]
22. Role of the Degree of Vascular Invasion in Predicting Prognosis of Follicular Thyroid Carcinoma.
Yamazaki H; Sugino K; Katoh R; Matsuzu K; Kitagawa W; Nagahama M; Rino Y; Saito A; Ito K
J Clin Endocrinol Metab; 2024 Apr; 109(5):1291-1300. PubMed ID: 38006314
[TBL] [Abstract][Full Text] [Related]
23. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
[TBL] [Abstract][Full Text] [Related]
24. Expression of long non-coding RNA H19 predicts distant metastasis in minimally invasive follicular thyroid carcinoma.
Dai Y; Miao Y; Zhu Q; Gao M; Hao F
Bioengineered; 2019 Dec; 10(1):383-389. PubMed ID: 31791180
[TBL] [Abstract][Full Text] [Related]
25. Clinical Implication of World Health Organization Classification in Patients with Follicular Thyroid Carcinoma in South Korea: A Multicenter Cohort Study.
Jin M; Kim ES; Kim BH; Kim HK; Yi HS; Jeon MJ; Kim TY; Kang HC; Kim WB; Shong YK; Kim M; Kim WG
Endocrinol Metab (Seoul); 2020 Sep; 35(3):618-627. PubMed ID: 32981304
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors for follicular thyroid carcinoma: the importance of vascular invasion.
Ito Y; Hirokawa M; Masuoka H; Higashiyama T; Kihara M; Onoda N; Miya A; Miyauchi A
Endocr J; 2022 Sep; 69(9):1149-1156. PubMed ID: 35491160
[TBL] [Abstract][Full Text] [Related]
27. Prognostic impact of extent of vascular invasion in low-grade encapsulated follicular cell-derived thyroid carcinomas: a clinicopathologic study of 276 cases.
Xu B; Wang L; Tuttle RM; Ganly I; Ghossein R
Hum Pathol; 2015 Dec; 46(12):1789-98. PubMed ID: 26482605
[TBL] [Abstract][Full Text] [Related]
28. Follicular and Hurthle cell carcinoma of the thyroid in iodine-sufficient area: retrospective analysis of Korean multicenter data.
Kim WG; Kim TY; Kim TH; Jang HW; Jo YS; Park YJ; Kim SW; Kim WB; Shong M; Park DJ; Chung JH; Shong YK; Cho BY
Korean J Intern Med; 2014 May; 29(3):325-33. PubMed ID: 24851067
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Significance of Extent of Invasion in Poorly Differentiated Thyroid Carcinoma.
Wong KS; Lorch JH; Alexander EK; Marqusee E; Cho NL; Nehs MA; Doherty GM; Barletta JA
Thyroid; 2019 Sep; 29(9):1255-1261. PubMed ID: 31397224
[No Abstract] [Full Text] [Related]
30. Follicular and Hurthle cell carcinomas of the thyroid: a comparative study.
Evans HL; Vassilopoulou-Sellin R
Am J Surg Pathol; 1998 Dec; 22(12):1512-20. PubMed ID: 9850177
[TBL] [Abstract][Full Text] [Related]
31. Preoperative sonographic features of follicular thyroid carcinoma predict biological behavior: A retrospective study.
Lai X; Jiang Y; Zhang B; Liang Z; Jiang Y; Li J; Zhao R; Yang X; Zhang X
Medicine (Baltimore); 2018 Oct; 97(41):e12814. PubMed ID: 30313115
[TBL] [Abstract][Full Text] [Related]
32. Minimally invasive follicular thyroid cancer: treat as a benign or malignant lesion?
Robinson A; Schneider D; Sippel R; Chen H
J Surg Res; 2017 Jan; 207():235-240. PubMed ID: 27979483
[TBL] [Abstract][Full Text] [Related]
33. Clinical, pathologic, and immunohistochemical prognostic factors in dogs with thyroid carcinoma.
Campos M; Ducatelle R; Rutteman G; Kooistra HS; Duchateau L; de Rooster H; Peremans K; Daminet S
J Vet Intern Med; 2014; 28(6):1805-13. PubMed ID: 25252127
[TBL] [Abstract][Full Text] [Related]
34. Expression of epithelial-mesenchymal transition regulators TWIST, SLUG and SNAIL in follicular thyroid tumours may relate to widely invasive, poorly differentiated and distant metastasis.
Wu J; Zhang Y; Cheng R; Gong W; Ding T; Zhai Q; Wang Y; Meng B; Sun B
Histopathology; 2019 Apr; 74(5):780-791. PubMed ID: 30368884
[TBL] [Abstract][Full Text] [Related]
35. Loss of estrogen receptor Beta expression in follicular thyroid carcinoma predicts poor outcome.
Heikkilä A; Hagström J; Mäenpää H; Louhimo J; Siironen P; Heiskanen I; Haglund C; Arola J
Thyroid; 2013 Apr; 23(4):456-65. PubMed ID: 23106428
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors of recurrence in encapsulated Hurthle cell carcinoma of the thyroid gland: a clinicopathologic study of 50 cases.
Ghossein RA; Hiltzik DH; Carlson DL; Patel S; Shaha A; Shah JP; Tuttle RM; Singh B
Cancer; 2006 Apr; 106(8):1669-76. PubMed ID: 16534796
[TBL] [Abstract][Full Text] [Related]
37. Hemithyroidectomy for low-risk follicular carcinoma of the thyroid: results from a regional hospital.
Chow TL; Tam SW; Choi CY; Kwan WW
Singapore Med J; 2018 Jun; 59(6):311-315. PubMed ID: 29214321
[TBL] [Abstract][Full Text] [Related]
38. Follicular variant of papillary thyroid carcinoma is a unique clinical entity: a population-based study of 10,740 cases.
Yu XM; Schneider DF; Leverson G; Chen H; Sippel RS
Thyroid; 2013 Oct; 23(10):1263-8. PubMed ID: 23477346
[TBL] [Abstract][Full Text] [Related]
39. Signet ring cell variant of follicular thyroid carcinoma: Report of two cases with focus on morphological, expressional and genetic characteristics.
Hysek M; Jatta K; Stenman A; Darai-Ramqvist E; Zedenius J; Höög A; Juhlin CC
Diagn Pathol; 2019 Nov; 14(1):127. PubMed ID: 31699114
[TBL] [Abstract][Full Text] [Related]
40. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
